Abbott India Limited appointed Mr. Vivek V Kamath as additional director of the company for a term of 5 years with effect from February 15, 2022, subject to the approval by the shareholders of the company. Vivek is also appointed as the key managerial personnel of the company effective from February 15, 2022. Since September 2019, Vivek has been working with Abbott Healthcare Private Limited as general manager of the specialty care business.

Prior to Abbott, worked with MSD Pharmaceuticals; Roche Diagnostics, India; Novartis, Singapore; Ranbaxy; Pfizer, India; Fulford, India; Wockhardt and Johnson & Johnson.